Archer Investment Corporation’s iShares Biotechnology ETF IBB Stock Holding History

Archer Investment Corporation’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72.1K	Hold	379	–	–	0.01%	504
2026 Q1	$64K	Hold	379	–	–	0.01%	489
2025 Q4	$63.9K	Buy	379 +1	+0.3%	+$162	0.01%	441
2025 Q3	$54.6K	Hold	378	–	–	0.01%	472
2025 Q2	$47.8K	Hold	378	–	–	0.01%	480
2025 Q1	$48.4K	Hold	378	–	–	0.01%	466
2024 Q4	$50K	Hold	378	–	–	0.01%	442
2024 Q3	$55K	Buy	378 +1	+0.3%	+$145	0.01%	427
2024 Q2	$51.8K	Hold	377	–	–	0.02%	422
2024 Q1	$51.8K	Hold	377	–	–	0.02%	408
2023 Q4	$51.2K	Buy	377 +1	+0.3%	+$122	0.02%	394
2023 Q3	$46K	Hold	376	–	–	0.02%	394
2023 Q2	$47.7K	Buy	+376	New	+$48.8K	0.02%	386
2021 Q1	–	Sell	-5,200	Closed	-$788K	–	760
2020 Q4	$788K	Hold	5,200	–	–	0.37%	61
2020 Q3	$704K	Hold	5,200	–	–	0.37%	63
2020 Q2	$711K	Hold	5,200	–	–	0.4%	57
2020 Q1	$560K	Hold	5,200	–	–	0.38%	62
2019 Q4	$627K	Buy	5,200 +1,700	+49%	+$190K	0.33%	68
2019 Q3	$348K	Hold	3,500	–	–	0.21%	125
2019 Q2	$382K	Buy	3,500 +3,464	+9,622%	+$368K	0.24%	97
2019 Q1	$4K	Buy	+36	New	+$3.95K	﹤0.01%	402

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Archer Investment Corporation's IBB Position: Q2 2026 in Review

Archer Investment Corporation held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 379 shares worth $72.1K. The position accounts for 0.01% of the portfolio, ranked #504.

Archer Investment Corporation first reported a position in IBB in Q1 2019 and has held it in 21 quarters since. The position peaked at $788K in Q4 2020. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Archer Investment Corporation held 379 shares of iShares Biotechnology ETF worth $72.1K as of Q2 2026.
Archer Investment Corporation left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #504 holding.
Archer Investment Corporation first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 21 quarters since.
Archer Investment Corporation's iShares Biotechnology ETF position peaked at $788K in Q4 2020.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.